112
Participants
Start Date
June 26, 2019
Primary Completion Date
January 30, 2024
Study Completion Date
January 30, 2024
Lofexidine
Lofexidine, sold under the brand name Lucemyra among others, is a medication historically used to treat high blood pressure, but more commonly used to help with the physical symptoms of opioid withdrawal. It is taken by mouth. It is an α2A adrenergic receptor agonist.
Placebo
Placebo comparator.
Medical University of South Carolina, Charleston
National Institutes of Health (NIH)
NIH
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER